Dr Will Dere on the ability to innovate | Amgen | Video

World Finance interviews Dr Will Dere, SVP and Chief Medical Officer at Amgen International, on their success and ability to innovate

May 10, 2010
Related Videos
  1. Investing in innovation: TITAN Group’s €40m commitment to transform construction
  2. TITAN Group: Sustainable and smart construction, powered by digital technology
Related:
  1. Inclusive finance and sustainable development
  2. Portugal leads Europe’s millionaire migration boom
  3. Insurance industry weathering the storm
  4. Banorte: a bank with passion and purpose
  5. Digital innovation reinforcing business leadership
  6. Tackling methane emissions in livestock: unlocking voluntary carbon credits
  7. Banking beyond borders
  8. The hidden risks in private credit’s $3trn boom
  9. Europe’s neobanks eye American wallets
  10. Saudi cuts spark global ripples
Transcript

Dr Will Dere talks about his work investigating blood disorders, kidney disease and cancer; and the success Amgen has had with its product Prolia in treating ovarian cancer and healing fractures faster.